Evidence map›Paper›PMID 27430720›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2016

Netrin-1 Augments Chemokinesis in CD4+ T Cells In Vitro and Elicits a Proinflammatory Response In Vivo.

Leo Boneschansker, Hironao Nakayama, Michele Eisenga, Johannes Wedel, Michael Klagsbrun, Daniel Irimia, David M Briscoe

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Immunomodulation by allograft endothelial cells.Frontiers in transplantation · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Netrin-1 in Glioblastoma Neovascularization: The New Partner in Crime?International journal of molecular sciences · 2021
    Review
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Urinary netrin-1 concentration in healthy full-term newborns.Archives of medical science : AMS · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Leo BoneschanskerTransplant Research Program, Division of Nephrology, Department of Medicine, Boston Children's Hospital, Boston, MA 02115; Department of Pediatrics, Harvard Medical School, Boston, MA 02115; Center for Engineering in Medicine, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Shriners Hospitals for Children, Boston, MA 02114; and.
Hironao NakayamaVascular Biology Program, Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.ORCID 0000-0002-9371-2650
Michele EisengaTransplant Research Program, Division of Nephrology, Department of Medicine, Boston Children's Hospital, Boston, MA 02115;ORCID 0000-0002-2484-6233
Johannes WedelTransplant Research Program, Division of Nephrology, Department of Medicine, Boston Children's Hospital, Boston, MA 02115; Department of Pediatrics, Harvard Medical School, Boston, MA 02115;ORCID 0000-0002-3490-8477
Michael KlagsbrunVascular Biology Program, Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.
Daniel IrimiaCenter for Engineering in Medicine, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Shriners Hospitals for Children, Boston, MA 02114; and.ORCID 0000-0001-7347-2082
David M BriscoeTransplant Research Program, Division of Nephrology, Department of Medicine, Boston Children's Hospital, Boston, MA 02115; Department of Pediatrics, Harvard Medical School, Boston, MA 02115; david.briscoe@childrens.harvard.edu.
Boston Children's Hospital · USShriners Hospitals for Children - Erie · US

Funding

Bio-MicroElectroMechanical Systems Resource CenterP41EB002503 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI TONER, MEHMET · 2004 to 2018
$17.4M
TRAINING IN TRANSPLANTATION BIOLOGYT32AI007529 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MADSEN, JOREN C · 1998 to 2024
$6.4M
RESEARCH TRAINING IN PEDIATRIC NEPHROLOGYT32DK007726 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI BRISCOE, DAVID M. · 1994 to 2023
$5.9M
Neutrophil Decision Making in Confined Environments in Health and DiseaseR01GM092804 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI IRIMIA, DANIEL · 2010 to 2022
$4.3M
ANGIOGENESIS AND CHRONIC REJECTIONR01AI046756 · NIAID · CHILDREN'S HOSPITAL BOSTON · PI BRISCOE, DAVID M. · 2000 to 2010
$4.2M
Vascular Endothelial Growth Factor Receptor Interactions and Allograft RejectionR01AI092305 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI BRISCOE, DAVID M. · 2012 to 2016
$2.8M
NIAID NIH HHS R01 AI046756NIAID NIH HHS R01 AI092305NIAID NIH HHS T32 AI007529NIBIB NIH HHS P41 EB002503NIDDK NIH HHS T32 DK007726NIGMS NIH HHS R01 GM092804
6 · The paper itself

Abstract

Netrin-1 is a neuronal guidance cue that regulates cellular activation, migration, and cytoskeleton rearrangement in multiple cell types. It is a chemotropic protein that is expressed within tissues and elicits both attractive and repulsive migratory responses. Netrin-1 has recently been found to modulate the immune response via the inhibition of neutrophil and macrophage migration. However, the ability of Netrin-1 to interact with lymphocytes and its in-depth effects on leukocyte migration are poorly understood. In this study, we profiled the mRNA and protein expression of known Netrin-1 receptors on human CD4(+) T cells. Neogenin, uncoordinated-5 (UNC5)A, and UNC5B were expressed at low levels in unstimulated cells, but they increased following mitogen-dependent activation. By immunofluorescence, we observed a cytoplasmic staining pattern of neogenin and UNC5A/B that also increased following activation. Using a novel microfluidic assay, we found that Netrin-1 stimulated bidirectional migration and enhanced the size of migratory subpopulations of mitogen-activated CD4(+) T cells, but it had no demonstrable effects on the migration of purified CD4(+)CD25(+)CD127(dim) T regulatory cells. Furthermore, using a short hairpin RNA knockdown approach, we observed that the promigratory effects of Netrin-1 on T effectors is dependent on its interactions with neogenin. In the humanized SCID mouse, local injection of Netrin-1 into skin enhanced inflammation and the number of neogenin-expressing CD3(+) T cell infiltrates. Neogenin was also observed on CD3(+) T cell infiltrates within human cardiac allograft biopsies with evidence of rejection. Collectively, our findings demonstrate that Netrin-1/neogenin interactions augment CD4(+) T cell chemokinesis and promote cellular infiltration in association with acute inflammation in vivo.

Indexed as

AnimalsBlotting, WesternCD4-Positive T-LymphocytesCells, CulturedChemotaxis, LeukocyteFlow CytometryFluorescent Antibody TechniqueHumansIn Vitro TechniquesMiceMice, SCIDMicrofluidic Analytical TechniquesNerve Growth FactorsNetrin-1Netrin ReceptorsReal-Time Polymerase Chain ReactionNerve Growth FactorsNetrin-1Netrin ReceptorsNTN1 protein, humanNtn1 protein, mouseReceptors, Cell SurfaceTumor Suppressor ProteinsUnc5A protein, mouse

Identifiers

PMID27430720
PMCPMC4976028
OpenAlexW2495109907

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.